3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
61
Carcinoma, Renal Cell
39
Neoplasm Metastasis
38
Neoplasms
24
Kidney Neoplasms
20
Neuroendocrine Tumors
19
Recurrence
16
Prostatic Neoplasms
15
Head and Neck Neoplasms
13
Tuberous Sclerosis
12
Triple Negative Breast Neoplasms
12
Lymphoma, Mantle-Cell
11
Hodgkin Disease
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma
10
Colorectal Neoplasms
10
Waldenstrom Macroglobulinemia
9
Stomach Neoplasms
9
Multiple Myeloma
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Glioma
9
Glioblastoma
9
Brain Neoplasms
9
Sarcoma
8
Pancreatic Neoplasms
8
Melanoma
8
Lymphoma, Follicular
8
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Interventions
Acupuncture Therapy
10
Exercise
6
Cryotherapy
6
Paclitaxel
5
Glutamine
4
Surveys and Questionnaires
3
Duloxetine Hydrochloride
3
Dexamethasone
3
Bortezomib
3
Acetylcysteine
3
Thioctic Acid
2
Tablets
2
Sodium Chloride
2
Saline Solution
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Fish Oils
2
Fatty Acids, Omega-3
2
ziconotide
1
nicotinamide-beta-riboside
1
glutamic acid diethyl ester
1
Yoga
1
XELOX
1
Vitamin D
1
Vitamin B Complex
1
Vitamin B 6
1
Vitamin B 12
1
Ultrasonic Therapy
1
Trimetazidine
1
Therapeutic Touch
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Peripheral Nervous System Diseases
×
Everolimus
×
Clear all
NCT01490476
2017-05-23
AFINF2
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
10 enrolled